Companies

FoldRx

Description: FoldRx Pharmaceuticals focuses on creating disease modifying drug therapies for diseases of protein misfolding. Their lead program, tafamidis, a first-in-class therapy for amyloidosis, has successfully completed a pivotal trial.

Location: Cambridge, MA

Sector: Healthcare

Year Invested: 2004

Status: Acquired by Pfizer

Back to Companies

Associated Team Members